• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与塞尔维亚恢复期血浆供者体内抗 SARS-CoV-2 抗体反应性相关的人口统计学和临床因素。

Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors.

机构信息

Blood Transfusion Institute Vojvodina, 21000 Novi Sad, Serbia.

Faculty of Medicine in Novi Sad, University of Novi Sad, 21000 Novi Sad, Serbia.

出版信息

Int J Environ Res Public Health. 2021 Dec 21;19(1):42. doi: 10.3390/ijerph19010042.

DOI:10.3390/ijerph19010042
PMID:35010301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8751168/
Abstract

Passive immunotherapy with convalescent COVID-19 plasma (CCP) is used as a therapeutic procedure in many countries, including Serbia. In this study, we analyzed the association between demographic factors, COVID-19 severity and the reactivity of anti-SARS-CoV-2 antibodies (Abs) in Serbian CCP donors. Individuals ( = 468) recovered from confirmed SARS-CoV-2 infection, and who were willing to donate their plasma for passive immunization of COVID-19 patients were enrolled in the study. Plasma samples were tested for the presence of IgG reactive to SARS-CoV-2 spike glycoprotein (S1) and nucleocapsid antigens. Individuals were characterized according to age, gender, comorbidities, COVID-19 severity, ABO blood type and RhD factor. Total of 420 candidates (420/468; 89.74%) reached the levels of anti-SARS-CoV-2 IgG that qualified them for inclusion in CCP donation program. Further statistical analysis showed that male individuals ( = 0.034), older age groups ( < 0.001), existence of hypertension ( = 0.008), and severe COVID-19 ( = 0.000) are linked with higher levels of anti-SARS-CoV-2 Abs. These findings will guide the selection of CCP donors in Serbia. Further studies need to be conducted to assess the neutralization potency and clinical efficiency of CCP collected from Serbian donors with high anti-SARS-CoV-2 IgG reactivity.

摘要

恢复期 COVID-19 血浆(CCP)的被动免疫疗法在许多国家(包括塞尔维亚)被用作治疗程序。在这项研究中,我们分析了塞尔维亚 CCP 供体的人口统计学因素、COVID-19 严重程度和抗 SARS-CoV-2 抗体(Abs)反应性之间的关联。从确诊的 SARS-CoV-2 感染中康复并愿意捐献其血浆用于 COVID-19 患者被动免疫的个体被纳入研究。检测血浆样本中是否存在针对 SARS-CoV-2 刺突糖蛋白(S1)和核衣壳抗原的 IgG。根据年龄、性别、合并症、COVID-19 严重程度、ABO 血型和 RhD 因子对个体进行特征描述。共有 420 名候选人(420/468;89.74%)达到了有资格纳入 CCP 捐献计划的抗 SARS-CoV-2 IgG 水平。进一步的统计分析表明,男性个体( = 0.034)、年龄较大的群体(<0.001)、存在高血压( = 0.008)和严重 COVID-19( = 0.000)与更高水平的抗 SARS-CoV-2 Abs 相关。这些发现将指导塞尔维亚 CCP 供体的选择。需要进一步研究评估来自具有高抗 SARS-CoV-2 IgG 反应性的塞尔维亚供体的 CCP 的中和效力和临床疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced7/8751168/02f539f6f0d4/ijerph-19-00042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced7/8751168/19c3026e4099/ijerph-19-00042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced7/8751168/02f539f6f0d4/ijerph-19-00042-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced7/8751168/19c3026e4099/ijerph-19-00042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ced7/8751168/02f539f6f0d4/ijerph-19-00042-g002.jpg

相似文献

1
Demographic and Clinical Factors Associated with Reactivity of Anti-SARS-CoV-2 Antibodies in Serbian Convalescent Plasma Donors.与塞尔维亚恢复期血浆供者体内抗 SARS-CoV-2 抗体反应性相关的人口统计学和临床因素。
Int J Environ Res Public Health. 2021 Dec 21;19(1):42. doi: 10.3390/ijerph19010042.
2
Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood group A donations.与 A 型血捐献者相比,O 型血恢复期血浆捐献者的 SARS-CoV-2 IgG 抗体水平显著较低。
Transfusion. 2021 Aug;61(8):2245-2249. doi: 10.1111/trf.16524. Epub 2021 May 27.
3
Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates.新型冠状病毒肺炎康复期血浆捐献者候选人群的临床特征与抗体水平的相关性。
Viruses. 2023 Jun 12;15(6):1357. doi: 10.3390/v15061357.
4
Simple prediction of COVID-19 convalescent plasma units with high levels of neutralization antibodies.用高滴度中和抗体简单预测 COVID-19 恢复期血浆单位。
Virol J. 2023 Mar 27;20(1):53. doi: 10.1186/s12985-023-02007-0.
5
SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.新型冠状病毒抗体亲和力在 COVID-19 患者和恢复期血浆捐献者中的反应。
J Infect Dis. 2020 Nov 13;222(12):1974-1984. doi: 10.1093/infdis/jiaa581.
6
The demographic and serological characteristics of COVID-19 convalescent plasma donors: Identification of basic criteria for optimal donor selection.COVID-19 恢复期血浆捐献者的人口统计学和血清学特征:确定最佳供者选择的基本标准。
Transfus Apher Sci. 2022 Apr;61(2):103302. doi: 10.1016/j.transci.2021.103302. Epub 2021 Oct 29.
7
SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study.无既往 COVID-19 症状史与有既往 COVID-19 症状史的献血者中 SARS-CoV-2 中和能力的比较研究。
Transfus Clin Biol. 2022 May;29(2):107-111. doi: 10.1016/j.tracli.2022.02.004. Epub 2022 Feb 12.
8
Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China.中国武汉 COVID-19 恢复期血浆采集试点项目的可行性。
Transfusion. 2020 Aug;60(8):1773-1777. doi: 10.1111/trf.15921. Epub 2020 Jul 31.
9
Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China.新冠肺炎恢复期全血献血者高 SARS-CoV-2 免疫球蛋白 G 滴度的预测因素:中国的一项横断面研究。
Front Immunol. 2023 Jun 14;14:1191479. doi: 10.3389/fimmu.2023.1191479. eCollection 2023.
10
Progression and Predictors of SARS-CoV-2 Antibody Seroreactivity In US Blood Donors.美国献血者中SARS-CoV-2抗体血清反应性的进展及预测因素
Transfus Med Rev. 2021 Jul;35(3):8-15. doi: 10.1016/j.tmrv.2021.07.003. Epub 2021 Jul 30.

引用本文的文献

1
Blood Group Variations in COVID-19 Convalescent Plasma and Regular Blood Donors: A Comparative Analysis in the Serbian Population.新冠康复者血浆与普通献血者的血型差异:塞尔维亚人群的比较分析
Microorganisms. 2024 Apr 30;12(5):915. doi: 10.3390/microorganisms12050915.
2
Factors associated with the SARS-CoV-2 immunoglobulin-G titer levels in convalescent whole-blood donors: a Chinese cross-sectional study.与恢复期全血供者中 SARS-CoV-2 免疫球蛋白-G 滴度相关的因素:一项中国的横断面研究。
Sci Rep. 2024 Mar 13;14(1):6072. doi: 10.1038/s41598-024-56462-y.
3
Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.

本文引用的文献

1
Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection.早期输注康复期血浆可改善重症新型冠状病毒2型感染的临床结局。
Infect Dis Ther. 2022 Feb;11(1):293-304. doi: 10.1007/s40121-021-00514-7. Epub 2021 Nov 24.
2
SARS-CoV-2, COVID-19 and the Ageing Immune System.SARS-CoV-2、COVID-19 和衰老的免疫系统。
Nat Aging. 2021 Sep;1(9):769-782. doi: 10.1038/s43587-021-00114-7. Epub 2021 Sep 14.
3
Relationship between blood type and outcomes following COVID-19 infection.COVID-19 感染后血型与结局的关系。
SARS-CoV-2 感染后 12 个月内特异性抗 SARS-CoV-2 IgM、IgA 和 IgG 反应的动力学:一项前瞻性纵向研究。
PLoS One. 2023 Jul 12;18(7):e0288557. doi: 10.1371/journal.pone.0288557. eCollection 2023.
4
Predictors of high SARS-CoV-2 immunoglobulin G titers in COVID-19 convalescent whole-blood donors: a cross-sectional study in China.新冠肺炎恢复期全血献血者高 SARS-CoV-2 免疫球蛋白 G 滴度的预测因素:中国的一项横断面研究。
Front Immunol. 2023 Jun 14;14:1191479. doi: 10.3389/fimmu.2023.1191479. eCollection 2023.
Semin Vasc Surg. 2021 Sep;34(3):125-131. doi: 10.1053/j.semvascsurg.2021.05.005. Epub 2021 Jul 18.
4
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.COVID-19 住院患者恢复期血浆治疗:一项开放标签、随机对照试验。
Nat Med. 2021 Nov;27(11):2012-2024. doi: 10.1038/s41591-021-01488-2. Epub 2021 Sep 9.
5
Analysis of the Behaviour of Immunoglobulin G Antibodies in Children and Adults Convalescing From Severe Acute Respiratory Syndrome-Coronavirus-2 Infection.严重急性呼吸综合征冠状病毒2感染康复期儿童和成人免疫球蛋白G抗体行为分析
Front Pediatr. 2021 Aug 17;9:671831. doi: 10.3389/fped.2021.671831. eCollection 2021.
6
Serological and viral genetic features of patients with COVID-19 in a selected German patient cohort-correlation with disease characteristics.COVID-19 患者在德国选定患者队列中的血清学和病毒遗传学特征-与疾病特征的相关性。
Geroscience. 2021 Oct;43(5):2249-2264. doi: 10.1007/s11357-021-00443-w. Epub 2021 Sep 1.
7
Antibody indexes in COVID-19 convalescent plasma donors: Unanswered questions.新型冠状病毒肺炎恢复期血浆捐献者的抗体指标:未解之谜。
Clinics (Sao Paulo). 2021 Aug 27;76:e2818. doi: 10.6061/clinics/2021/e2818. eCollection 2021.
8
Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)突变对抗体治疗疗效和疫苗反应的影响。
Vaccines (Basel). 2021 Aug 17;9(8):914. doi: 10.3390/vaccines9080914.
9
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination.对自然感染新冠病毒2型或接种新冠疫苗后的抗体反应。
Vaccines (Basel). 2021 Aug 16;9(8):910. doi: 10.3390/vaccines9080910.
10
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma.SARS-CoV-2 从高中和性的 COVID-19 恢复期血浆中逃逸。
Proc Natl Acad Sci U S A. 2021 Sep 7;118(36). doi: 10.1073/pnas.2103154118.